BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 22251530)

  • 21. Should we eradicate Helicobacter pylori infection in patients receiving nonsteroidal anti-inflammatory drugs or low-dose aspirin?
    Chan FK
    Chin J Dig Dis; 2005; 6(1):1-5. PubMed ID: 15667550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The significance of H. pylori eradication in NSAIDs ulcer].
    Kato M; Ono S; Mabe K; Shimizu Y; Asaka M
    Nihon Rinsho; 2011 Jun; 69(6):1049-56. PubMed ID: 21688626
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endoscopic characteristics and Helicobacter pylori infection in NSAID-associated gastric ulcer.
    Kamada T; Hata J; Kusunoki H; Sugiu K; Tanimoto T; Mihara M; Hamada H; Kido S; Dongmei Q; Haruma K
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):98-102. PubMed ID: 16706819
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonsteroidal anti-inflammatory drugs, Helicobacter pylori, and ulcers: where we stand.
    Graham DY
    Am J Gastroenterol; 1996 Oct; 91(10):2080-6. PubMed ID: 8855725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical features and diagnosis of non-steroidal anti-inflammatory drugs induced ulcers of the stomach].
    Watari J; Kim Y; Yokoyama S; Hori K; Miwa H
    Nihon Rinsho; 2011 Jun; 69(6):1016-23. PubMed ID: 21688621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ulcer site and complications: relation to Helicobacter pylori infection and NSAID use.
    al-Assi MT; Genta RM; Karttunen TJ; Graham DY
    Endoscopy; 1996 Feb; 28(2):229-33. PubMed ID: 8739738
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Helicobacter pylori eradication may reduce the risk of gastroduodenal lesions in chronic NSAID users.
    Russell RI
    Ital J Gastroenterol Hepatol; 1997 Oct; 29(5):465-9. PubMed ID: 9494858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Current state and measures of NSAIDs induced ulcer].
    Mizokami Y; Narasaka T; Suzuki H
    Nihon Rinsho; 2011 Oct; 69(10):1901-5. PubMed ID: 22073592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-steroidal anti-inflammatory drugs (NSAID) cause gastrointestinal ulcers mainly in Helicobacter pylori carriers.
    Publig W; Wüstinger C; Zandl C
    Wien Klin Wochenschr; 1994; 106(9):276-9. PubMed ID: 8023522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Helicobacter pylori increases the risk of peptic ulcer bleeding: a case-control study.
    Labenz J; Peitz U; Köhl H; Kaiser J; Malfertheiner P; Hackelsberger A; Börsch G
    Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):110-5. PubMed ID: 10363194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peptic ulcer disease today.
    Yuan Y; Padol IT; Hunt RH
    Nat Clin Pract Gastroenterol Hepatol; 2006 Feb; 3(2):80-9. PubMed ID: 16456574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of Helicobacter pylori infection in peptic ulcer haemorrhage.
    Morgando A; Giordanino C; Baronio M; Pellicano R; Rizzetto M
    Minerva Med; 2006 Feb; 97(1):47-50. PubMed ID: 16565698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Should Helicobacter pylori infection be tested and eradicated in patients treated or about to be treated with aspirin or nonsteroidal anti-inflammatory drugs?].
    Thiéfin G
    Gastroenterol Clin Biol; 2003 Mar; 27(3 Pt 2):415-26. PubMed ID: 12700498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Bleeding peptic ulcer. Prevalence of Helicobacter pylori and use of nonsteroidal anti-inflammatory drugs/acetylsalicylic acid].
    Vestergård A; Bredahl K; de Muckadell OB; Pedersen OB; Hansen JM
    Ugeskr Laeger; 2009 Jan; 171(4):235-9. PubMed ID: 19174039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of Helicobacter pylori infection in duodenal ulcer and gastro-duodenal ulcer diseases in Taiwan.
    Chen TS; Luo JC; Chang FY
    J Gastroenterol Hepatol; 2010 May; 25(5):919-22. PubMed ID: 20074147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prevalence of peptic ulcer not related to Helicobacter pylori or non-steroidal anti-inflammatory drug use is negligible in southern Europe.
    Arroyo MT; Forne M; de Argila CM; Feu F; Arenas J; de la Vega J; Garrigues V; Mora F; Castro M; Bujanda L; Cosme A; Castiella A; Gisbert JP; Hervas A; Lanas A
    Helicobacter; 2004 Jun; 9(3):249-54. PubMed ID: 15165261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of cocaine and methamphetamine use with giant gastroduodenal ulcers.
    Pecha RE; Prindiville T; Pecha BS; Camp R; Carroll M; Trudeau W
    Am J Gastroenterol; 1996 Dec; 91(12):2523-7. PubMed ID: 8946979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
    Goldstein JL; Huang B; Amer F; Christopoulos NG
    Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proton-pump inhibitors are associated with a reduced risk for bleeding and perforated gastroduodenal ulcers attributable to non-steroidal anti-inflammatory drugs: a nested case-control study.
    Vonkeman HE; Fernandes RW; van der Palen J; van Roon EN; van de Laar MA
    Arthritis Res Ther; 2007; 9(3):R52. PubMed ID: 17521422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong Kong.
    Xia B; Xia HH; Ma CW; Wong KW; Fung FM; Hui CK; Chan CK; Chan AO; Lai KC; Yuen MF; Wong BC
    Aliment Pharmacol Ther; 2005 Aug; 22(3):243-9. PubMed ID: 16091062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.